PT3402783T - Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diazaespiro- [4,5]-decano - Google Patents
Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diazaespiro- [4,5]-decanoInfo
- Publication number
- PT3402783T PT3402783T PT177004744T PT17700474T PT3402783T PT 3402783 T PT3402783 T PT 3402783T PT 177004744 T PT177004744 T PT 177004744T PT 17700474 T PT17700474 T PT 17700474T PT 3402783 T PT3402783 T PT 3402783T
- Authority
- PT
- Portugal
- Prior art keywords
- diaza
- carboxyethyl
- spiro
- oxo
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16151011 | 2016-01-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT3402783T true PT3402783T (pt) | 2020-07-03 |
Family
ID=55129632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT177004744T PT3402783T (pt) | 2016-01-13 | 2017-01-13 | Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diazaespiro- [4,5]-decano |
Country Status (27)
Country | Link |
---|---|
US (7) | US20170197919A1 (pt) |
EP (2) | EP3722283A1 (pt) |
JP (2) | JP6862457B2 (pt) |
KR (1) | KR20180100592A (pt) |
CN (1) | CN108699005B (pt) |
AR (1) | AR107361A1 (pt) |
AU (1) | AU2017207467B2 (pt) |
BR (1) | BR112018014302B1 (pt) |
CA (1) | CA3011175C (pt) |
CL (1) | CL2018001913A1 (pt) |
CO (1) | CO2018008445A2 (pt) |
CY (1) | CY1122882T1 (pt) |
DK (1) | DK3402783T3 (pt) |
EA (1) | EA037649B1 (pt) |
EC (1) | ECSP18060820A (pt) |
ES (1) | ES2803354T3 (pt) |
HR (1) | HRP20200656T1 (pt) |
HU (1) | HUE049374T2 (pt) |
IL (1) | IL260495B (pt) |
LT (1) | LT3402783T (pt) |
MX (1) | MX2018008640A (pt) |
PL (1) | PL3402783T3 (pt) |
PT (1) | PT3402783T (pt) |
RS (1) | RS60223B1 (pt) |
SI (1) | SI3402783T1 (pt) |
TW (1) | TWI635081B (pt) |
WO (1) | WO2017121646A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI635082B (zh) | 2016-01-13 | 2018-09-11 | 歌林達有限公司 | 3-((雜-)芳基)-8-胺基-2-側氧-1,3-二氮雜-螺-[4.5]-癸烷衍生物 |
DK3402785T3 (da) | 2016-01-13 | 2020-04-20 | Gruenenthal Gmbh | 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater |
AU2017206911B2 (en) | 2016-01-13 | 2020-07-09 | Grünenthal GmbH | 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
PL3402784T3 (pl) | 2016-01-13 | 2020-09-21 | Grünenthal GmbH | Pochodne 3-((hetero-)arylo)-alkilo-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekanu |
PL3402783T3 (pl) * | 2016-01-13 | 2020-08-24 | Grünenthal GmbH | Pochodne 3-(karboksyetylo)-8-amino-2-okso-1,3-diazaspiro-[4.5]-dekanu |
WO2024223726A1 (en) | 2023-04-25 | 2024-10-31 | Grünenthal GmbH | Cis-8-(3,5-difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2734265B1 (fr) | 1995-05-17 | 1997-06-13 | Adir | Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant |
CA2444108C (en) | 2001-04-18 | 2012-07-24 | Euro-Celtique, S.A. | Nociceptin analogs |
DE10130020A1 (de) | 2001-06-25 | 2003-12-04 | Gruenenthal Gmbh | Substituierte 1-Oxa-2,8-diaza-spiro[4.5]dec-2-en-derivate |
DE10210195B4 (de) | 2002-03-07 | 2005-12-15 | Schwarz Pharma Ag | Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz |
DE10252667A1 (de) | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
AU2004241134A1 (en) | 2003-05-23 | 2004-12-02 | Zealand Pharma A/S | Triaza-spiro compounds as nociceptin analogues and uses thereof |
JO2676B1 (en) | 2004-04-06 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines |
KR20110079776A (ko) | 2006-10-19 | 2011-07-07 | 에프. 호프만-라 로슈 아게 | 당뇨병을 위한 11베타-에이치에스디1 억제제로서의 이미다졸론 및 이미다졸리딘온 유도체 |
CA2683598C (en) | 2007-04-09 | 2015-11-17 | Janssen Pharmaceutica Nv | 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression |
KR20100136521A (ko) * | 2008-03-27 | 2010-12-28 | 그뤼넨탈 게엠베하 | 치환된 4-아미노사이클로헥산 유도체 |
TWI582092B (zh) | 2010-07-28 | 2017-05-11 | 歌林達股份有限公司 | 順式-四氫-螺旋(環己烷-1,1’-吡啶[3,4-b]吲哚)-4-胺-衍生物 |
AU2013369649B2 (en) * | 2012-12-31 | 2018-07-26 | Sunovion Pharmaceuticals Inc. | Heterocyclic compounds and methods of use thereof |
WO2015192039A1 (en) | 2014-06-13 | 2015-12-17 | Purdue Pharma L.P. | Heterocyclic morphinan derivatives and use thereof |
DK3402785T3 (da) | 2016-01-13 | 2020-04-20 | Gruenenthal Gmbh | 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater |
AU2017206911B2 (en) | 2016-01-13 | 2020-07-09 | Grünenthal GmbH | 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
PL3402784T3 (pl) | 2016-01-13 | 2020-09-21 | Grünenthal GmbH | Pochodne 3-((hetero-)arylo)-alkilo-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekanu |
PL3402783T3 (pl) * | 2016-01-13 | 2020-08-24 | Grünenthal GmbH | Pochodne 3-(karboksyetylo)-8-amino-2-okso-1,3-diazaspiro-[4.5]-dekanu |
-
2017
- 2017-01-13 PL PL17700474T patent/PL3402783T3/pl unknown
- 2017-01-13 CA CA3011175A patent/CA3011175C/en active Active
- 2017-01-13 WO PCT/EP2017/025004 patent/WO2017121646A1/en active Application Filing
- 2017-01-13 KR KR1020187021561A patent/KR20180100592A/ko not_active Application Discontinuation
- 2017-01-13 DK DK17700474.4T patent/DK3402783T3/da active
- 2017-01-13 HU HUE17700474A patent/HUE049374T2/hu unknown
- 2017-01-13 BR BR112018014302-2A patent/BR112018014302B1/pt active IP Right Grant
- 2017-01-13 EP EP20155667.7A patent/EP3722283A1/en active Pending
- 2017-01-13 AR ARP170100096A patent/AR107361A1/es unknown
- 2017-01-13 SI SI201730241T patent/SI3402783T1/sl unknown
- 2017-01-13 TW TW106101123A patent/TWI635081B/zh active
- 2017-01-13 LT LTEP17700474.4T patent/LT3402783T/lt unknown
- 2017-01-13 RS RS20200519A patent/RS60223B1/sr unknown
- 2017-01-13 MX MX2018008640A patent/MX2018008640A/es unknown
- 2017-01-13 EP EP17700474.4A patent/EP3402783B1/en active Active
- 2017-01-13 US US15/405,482 patent/US20170197919A1/en not_active Abandoned
- 2017-01-13 CN CN201780006500.8A patent/CN108699005B/zh active Active
- 2017-01-13 ES ES17700474T patent/ES2803354T3/es active Active
- 2017-01-13 PT PT177004744T patent/PT3402783T/pt unknown
- 2017-01-13 JP JP2018536433A patent/JP6862457B2/ja active Active
- 2017-01-13 EA EA201891610A patent/EA037649B1/ru unknown
- 2017-01-13 AU AU2017207467A patent/AU2017207467B2/en active Active
-
2018
- 2018-05-15 US US15/979,932 patent/US20180273491A1/en not_active Abandoned
- 2018-07-09 IL IL260495A patent/IL260495B/en unknown
- 2018-07-13 CL CL2018001913A patent/CL2018001913A1/es unknown
- 2018-08-13 EC ECSENADI201860820A patent/ECSP18060820A/es unknown
- 2018-08-13 CO CONC2018/0008445A patent/CO2018008445A2/es unknown
- 2018-12-03 US US16/207,676 patent/US20190100497A1/en not_active Abandoned
-
2019
- 2019-06-24 US US16/450,406 patent/US10793528B2/en active Active
-
2020
- 2020-04-23 HR HRP20200656TT patent/HRP20200656T1/hr unknown
- 2020-05-06 CY CY20201100416T patent/CY1122882T1/el unknown
- 2020-08-31 US US17/007,374 patent/US20200399226A1/en not_active Abandoned
-
2021
- 2021-03-01 US US17/188,802 patent/US20210214315A1/en not_active Abandoned
- 2021-03-30 JP JP2021056938A patent/JP7148665B2/ja active Active
-
2023
- 2023-01-30 US US18/102,983 patent/US20230183184A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL264092A (en) | 1, 3-dihydroxy-phenyl derivatives are useful as immunomodulators | |
IL260488B (en) | History of 8-amino-2-oxo-3,1-diaza-spiro-[5.4]-decane | |
IL260491B (en) | History of 3-((hetero-)aryl)-alkyl-8-amino-2-oxo-3,1-diaza-spiro-[5.4]-decane | |
IL260495B (en) | History of 3-(carboxyethyl)-8-amino-2-oxo-3,1-diaza-spiro-[5.4]-decane | |
IL260497B (en) | History of 3-(Carboxymethyl)-8-amino-2-oxo-3,1-diaza-spiro-[5.4]-decane | |
IL285355A (en) | History of 3-((hetero-)aryl)-8-amino-2-oxo-3,1-diaza-spiro-[5.4]-decane | |
SG11201803584RA (en) | 1,4-dicarbonyl-piperidyl derivatives | |
HK1254800A1 (zh) | 2,3,4,5-四氫吡啶-6-胺衍生物 | |
HRP20180940T1 (hr) | Derivati supstituiranog azaspiro(4,5)dekana | |
SI3484892T1 (sl) | Derivati 1,2,4-triazolo-(3,4-B)-1,3,4-tiadiazola | |
GB201600418D0 (en) | Products, uses & methods (1.2) |